Comparing long-term outcomes between drug-eluting and bare-metal stents in the treatment of cardiac allograft vasculopathy

Catheterization and Cardiovascular Interventions

Volumn 74, Issue 4, 2009, Pages 543-549

  Nfor, Tonga ^a   Ansaarie, Imran ^a   Gupta, Anjan ^a   Bajwa, Tanvir ^a   Allaqaband, Suhail ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Adverse cardiac events; Coronary restenosis; Heart transplantation; Percutaneous coronary intervention; Stents

Indexed keywords

CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PACLITAXEL; RAPAMYCIN;

ACUTE HEART INFARCTION; ADULT; ARTICLE; BARE METAL STENT; CARDIAC ALLOGRAFT VASCULOPATHY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DRUG ELUTING STENT; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HEART TRANSPLANTATION; HUMAN; IN-STENT RESTENOSIS; INCIDENCE; INTERMETHOD COMPARISON; MALE; MORTALITY; PROGNOSIS; REVASCULARIZATION; VASCULAR PATENCY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; CORONARY STENOSIS; DRUG-ELUTING STENTS; FEMALE; HEART DISEASES; HEART TRANSPLANTATION; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; METALS; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSTHESIS DESIGN; REGISTRIES; RISK ASSESSMENT; STENTS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; WISCONSIN;

EID: 70350586702     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.22058     Document Type: Article

References (31)

1. Gallo P, Agozzino L, Angelini A, Arbustini E, Bartoloni G, Bernucci P, Bonacina E, Bosman C, Catani G, Di Gioia C. Causes of late failure after heart transplantation: A ten-year survey. J Heart Lung Transplant 1997;16:1113-1121.
2. Costanzo MR, Naftel DC, Pritzker MR, Heilman JK 3rd, Boehmer JP, Brozena SC, Dec GW, Ventura HO, Kirklin JK, Bourge RC, Miller LW. Heart transplant coronary artery disease detected by coronary angiography: A multiinstitutional study of preoperative donor and recipient risk factors. Cardiac transplant research database. J Heart Lung Transplant 1998;17:744-753.
3. Valantine H. Cardiac allograft vasculopathy after heart transplantation: Risk factors and management. J Heart Lung Transplant 2004;23:S187-S193. (Pubitemid 38496395)
4. Billingham ME. Histopathology of graft coronary disease. J Heart Lung Transplant 1992;11:S38-S44.
5. Pinney SP, Mancini D. Cardiac allograft vasculopathy: Advances in understanding its pathophysiology, prevention, and treatment. Curr Opin Cardiol 2004;19:170-176. (Pubitemid 38373134)
6. Kobashigawa JA, Katznelson S, Laks H, Johnson JA, Yeatman L, Wang XM, Chia D, Terasaki PI, Sabad A, Cogert GA. Effect of pravastatin on outcomes after cardiac transplantation. N Engl J Med 1995;333:621-627.
7. Mehra MR, Uber PA, Vivekananthan K, Solis S, Scott RL, Park MH, Milani RV, Lavie CJ. Comparative beneficial effects of simvastatin and pravastatin on cardiac allograft rejection and survival. J Am Coll Cardiol 2002;40:1609-1614. (Pubitemid 35256143)
8. Wenke K, Meiser B, Thiery J, Nagel D, von Scheidt W, Krobot K, Steinbeck G, Seidel D, Reichart B. Simvastatin initiated early after heart transplantation 8-year prospective experience. Circulation 2003;107:93-97. (Pubitemid 36070939)
9. Keogh A, Richardson M, Ruygrok P, Spratt P, Galbraith A, O'Driscoll G, Macdonald P, Esmore D, Muller D, Faddy S. Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2 years: A randomized clinical trial. Circulation 2004;110:2694-2700.
10. Eisen HJ, Tuzcu EM, Dorent R, Kobashigawa J, Mancini D, Valantine-von Kaeppler HA, Starling RC, Sorensen K, Hummel M, Lind JM. Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients. N Engl J Med 2003;349:847.
11. Musci M, Loebe M, Wellnhofer E, Meyer R, Pasic M, Hummel M, Bocksch W, Grauhan O, Weng Y, Hetzer R. Coronary angioplasty, bypass surgery, and retransplantation in cardiac transplant patients with graft coronary disease. Thorac Cardiovasc Surg 1998;46:268-274. (Pubitemid 28562036)
12. Halle AA, DiSciascio G, Massin EK, Wilson RF, Johnson MR, Sullivan HJ, Bourge RC, Kleiman NS, Miller LW, Aversano TR. Coronary angioplasty, atherectomy and bypass surgery in cardiac transplant recipients. J Am Coll Cardiol 1995;26:120-128.
13. Srivastava R, Keck BM, Bennett LE, Hosenpud JD. The results of cardiac retransplantation: An analysis of the joint international society for heart and lung transplantation/United network for organ sharing thoracic registry. Transplantation 2000;70:606-612. (Pubitemid 30659645)
14. Smith SC Jr, Feldman TE, Hirshfeld JW Jr, Jacobs AK, Kern MJ, King SB. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: A report of the american college of Cardiology/American heart association task force on practice guidelines. Circulation 2006;113:e166-e286.
15. Halle AA III, Wilson RF, Massin EK, Bourge RC, Stadius ML, Johnson MR, Wray RB, Young JB, Davies RA, Walford GD. Coronary angioplasty in cardiac transplant patients. results of a multicenter study. Circulation 1992;86:458-462.
16. Heublein B, Pethig K, Maass C, Wahlers T, Haverich A. Coronary artery stenting in cardiac allograft vascular disease. Am Heart J 1997;134:930-938. (Pubitemid 27522999)
17. Schnetzler B, Drobinski G, Dorent R, Camproux AC, Ghossoub J, Thomas D, Gandjbakhch I. The role of percutaneous transluminal coronary angioplasty in heart transplant recipients. J Heart Lung Transplant 2000;19:557-565.
18. Doshi AA, Rogers J, Kern MJ, Hauptman PJ. Effectiveness of percutaneous coronary intervention in cardiac allograft vasculopathy. Am J Cardiol 2004;93:90-92. (Pubitemid 38022042)
19. Benza RL, Zoghbi GJ, Tallaj J, Brown R, Kirklin JK, Hubbard M, Rayburn B, Foley B, McGiffin DC, Pinderski LJ. Palliation of allograft vasculopathy with transluminal angioplasty A decade of experience. J Am Coll Cardiol 2004;43:1973-1981. (Pubitemid 38691130)
20. Simpson L, Lee EK, Hott BJ, Vega DJ, Book WM. Long-term results of angioplasty vs stenting in cardiac transplant recipients with allograft vasculopathy. J Heart Lung Transplant 2005;24:1211-1217. (Pubitemid 41247800)
21. Tanaka K, Li H, Curran PJ, Takano Y, Arbit B, Currier JW, Yeatman LA, Kobashigawa JA, Tobis JM. Usefulness and safety of percutaneous coronary interventions for cardiac transplant vasculopathy. Am J Cardiol 2006;97:1192-1197.
22. Bader FM, Kfoury AG, Gilbert EM, Barry WH, Humayun N, Hagan ME, Thomas H, Renlund D. Percutaneous coronary interventions with stents in cardiac transplant recipients. J Heart Lung Transplant 2006;25:298-301. (Pubitemid 43290660)
23. Dibra A, Kastrati A, Mehilli J, Pache J, Schuhlen H, von Beckerath N, Ulm K, Wessely R, Dirschinger J, Schomig A. Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients. N Engl J Med 2005;353:663-670. (Pubitemid 41175674)
24. Ardissino D, Cavallini C, Bramucci E, Indolfi C, Marzocchi A, Manari A, Angeloni G, Carosio G, Bonizzoni E, Colusso S. Sirolimus-eluting vs uncoated stents for prevention of restenosis in small coronary arteries. A randomized trial. JAMA 2004;292:2727-2734. (Pubitemid 39628251)
25. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, Caputo RP, Kereiakes DJ, Williams DO, Teirstein PS. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349:1315-1323.
26. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004;350:221-231.
27. Habara S, Mitsudo K, Goto T, Kadota K, Fujii S, Yamamoto H, Kato H, Takenaka S, Fuku Y, Hosogi S. The impact of lesion length and vessel size on outcomes after sirolimus-eluting stent implantation for in-stent restenosis. Br Med J 2008;94:1162-1165.
28. Colombo A, Orlic D, Stankovic G, Corvaja N, Spanos V, Montorfano M, Liistro F, Carlino M, Airoldi F, Chieffo A. Preliminary observations regarding angiographic pattern of restenosis after rapamycin- eluting stent implantation. Circulation 2003;107:2178-2180. (Pubitemid 36547208)
29. Costa MA, Simon DI. Molecular basis of restenosis and drugeluting stents. Circulation 2005;111:2257-2273.
30. Zakliczynski M, Lekston A, Osuch M, Swierad M, Nadziakiewicz P, Przybylski R, Zembala M. Comparison of long-term results of drug-eluting stent and bare metal stent implantation in heart transplant recipients with coronary artery disease. Transplant Proc 2007;39:2859-2861.
31. Wellnhofer E, Hiemann NE, Hug J, Dreysse S, Knosalla C, Graf K, Meyer R, Lehmkuhl HB, Hetzer R, Fleck E. A decade of percutaneous coronary interventions in cardiac transplant recipients: A monocentric study in 160 patients. J Heart Lung Transplant 2008;27:17-25.